The FDA has approved Tauvid for PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles.
Older adults with both dementia and self-reported visual impairment may be at higher risk for disability than adults with only one of these conditions.
A subset of patients at risk for Alzheimer disease because of systemic inflammation may benefit from receiving a tumor necrosis factor blocking agent.
Researchers explored the association between midlife serum uric acid and the risk for cognitive decline and dementia.
Previous research has suggested that treatment with metformin may potentially lower the risk of dementia, however whether the timing of treatment impacts this result remains unclear.
The risk for AD among patients with psoriasis was significantly increased in psoriasis patients not receiving systemic therapy compared with those receiving systemic therapy.
Many cognitive tests can differentiate clinical Alzheimer-type dementia from normal cognition.
Use of benzodiazepines, Z-drugs, or other anxiolytics was not associated with incident dementia in either the cohort or nested case-control design.
In older women, objectively measured visual impairment is associated with a twofold to more than fivefold increased risk for dementia.
the gene variant may be protective in those aged 60 to 80 years, cognitively normal, who carry APOE4.